Treatment with both IL-6 or supernatant from MM-derived bone marrow stromal cell suppressed the expression of miR-23b (Figure 2d) in a time- and dose-dependent pattern (data not shown). This evidence concerns the gene IL6 and Miyoshi myopathy.